المؤلفون: Wan, Zhengpeng^1,2 (AUTHOR), Zhang, Shun^1,3,4 (AUTHOR), Zhong, Amy X.¹ (AUTHOR), Xu, Liling⁵ (AUTHOR), Coughlin, Mark F.¹ (AUTHOR), Pavlou, Georgios¹ (AUTHOR), Shelton, Sarah E.^1,2 (AUTHOR), Nguyen, Huu Tuan¹ (AUTHOR), Hirose, Satomi¹ (AUTHOR), Kim, Seunggyu¹ (AUTHOR), Floryan, Marie A.¹ (AUTHOR), Barbie, David A.² (AUTHOR), Hodi, F. Stephen^2,6 (AUTHOR) stephen_hodi@dfci.harvard.edu, Kamm, Roger D.^1,7 (AUTHOR) rdkamm@mit.edu

المصدر: Advanced Science. 7/10/2024, Vol. 11 Issue 26, p1-10. 10p.

مصطلحات موضوعية: *PROGRAMMED death-ligand 1, *MICROFLUIDIC devices, *FLUID flow, *TUMOR microenvironment, *ENDOTHELIAL cells, *INTEGRINS

المؤلفون: Somme, Laura Bender¹ (AUTHOR) l.bender@icans.eu, Chouaid, Christos² (AUTHOR), Moinard-Butot, Fabien¹ (AUTHOR), Barbe-Richaud, Jean-Baptiste¹ (AUTHOR), Greillier, Laurent³ (AUTHOR), Schott, Roland¹ (AUTHOR)

المصدر: BioDrugs. Jul2024, Vol. 38 Issue 4, p487-497. 11p.

مصطلحات موضوعية: *ANTIBODY-drug conjugates, *PROGRAMMED death-ligand 1, *TRANSITIONAL cell carcinoma, *IMMUNE checkpoint inhibitors, *CARCINOMA

المؤلفون: Nagasaki, Yusuke^1,2,3 (AUTHOR), Taki, Tetsuro¹ (AUTHOR) tetaki@east.ncc.go.jp, Nomura, Kotaro² (AUTHOR), Tane, Kenta² (AUTHOR), Miyoshi, Tomohiro² (AUTHOR), Samejima, Joji² (AUTHOR), Aokage, Keiju² (AUTHOR), Ohtani-Kim, Seiyu Jeong-Yoo^1,2 (AUTHOR), Kojima, Motohiro^1,4 (AUTHOR), Sakashita, Shingo^1,4 (AUTHOR), Sakamoto, Naoya^1,4 (AUTHOR), Ishikawa, Shumpei^4,5 (AUTHOR), Suzuki, Kenji³ (AUTHOR), Tsuboi, Masahiro² (AUTHOR), Ishii, Genichiro^1,6 (AUTHOR)

المصدر: JNCI: Journal of the National Cancer Institute. Jul2024, Vol. 116 Issue 7, p1158-1168. 11p.

مصطلحات موضوعية: *PROGRAMMED death-ligand 1, *NON-small-cell lung carcinoma, *TEXTURE analysis (Image processing), *HETEROGENEITY, *SQUAMOUS cell carcinoma

المؤلفون: Sun, Belinda L¹ (AUTHOR) bsun@pathology.arizona.edu, Elliott, Alexis S¹ (AUTHOR), Nolte, David¹ (AUTHOR), Sun, Xiaoguang² (AUTHOR)

المصدر: American Journal of Clinical Pathology. Jul2024, Vol. 162 Issue 1, p17-27. 11p.

مصطلحات موضوعية: *PROGRAMMED death-ligand 1, *IMMUNE checkpoint proteins, *COLITIS, *DRUG side effects, *IMMUNE checkpoint inhibitors

المؤلفون: Huang, Hsien-Neng^1,2 (AUTHOR), Kuo, Chun-Wei¹ (AUTHOR), Hung, Yu-Ling³ (AUTHOR), Yang, Chia-Hung³ (AUTHOR), Hsieh, Yu-Han³ (AUTHOR), Lin, Yu-Chieh³ (AUTHOR), Chang, Margaret Dah-Tsyr³ (AUTHOR), Lin, Yen-Yin³ (AUTHOR), Ko, Jen-Chung⁴ (AUTHOR) e1205470@ms22.hinet.net

المصدر: Scientific Reports. 7/2/2024, Vol. 14 Issue 1, p1-11. 11p.

مصطلحات موضوعية: *IMMUNOFLUORESCENCE, *PROGRAMMED death-ligand 1, *NON-small-cell lung carcinoma, *PATHOLOGY

المؤلفون: Arthur, Axel^1,2,3 (AUTHOR), Nejmi, Sanae^1,2,3 (AUTHOR), Franchini, Don-Marc^1,2,4,5,6,7 (AUTHOR), Espinos, Estelle^1,2,3 (AUTHOR), Millevoi, Stefania^1,2,3 (AUTHOR) stefania.millevoi@inserm.fr

المصدر: Trends in Molecular Medicine. Jul2024, Vol. 30 Issue 7, p620-632. 13p.

مصطلحات موضوعية: *RNA metabolism, *PROGRAMMED death-ligand 1, *IMMUNE checkpoint proteins, *RNA methylation, *GENE expression

المؤلفون: Kim, Hyung-Don¹ (AUTHOR), Shin, Jinho² (AUTHOR), Song, In Hye² (AUTHOR), Hyung, Jaewon¹ (AUTHOR), Lee, Hyungeun¹ (AUTHOR), Ryu, Min-Hee¹ (AUTHOR) miniryu@amc.seoul.kr, Park, Young Soo² (AUTHOR)

المصدر: Gastric Cancer. Jul2024, Vol. 27 Issue 4, p819-826. 8p.

مصطلحات موضوعية: *CANCER prognosis, *PROGRAMMED death-ligand 1, *NIVOLUMAB, *INTRACLASS correlation, *TREATMENT effectiveness

المؤلفون: Hempenius, Maaike Anna¹ (AUTHOR) m.a.hempenius@umcg.nl, Koomen, Bregje M² (AUTHOR), Deckers, Ivette A G³ (AUTHOR), Oosting, Sjoukje F⁴ (AUTHOR), Willems, Stefan M¹ (AUTHOR), van der Vegt, Bert¹ (AUTHOR)

المصدر: Histopathology. Jul2024, Vol. 85 Issue 1, p133-142. 10p.

مصطلحات موضوعية: *SQUAMOUS cell carcinoma, *PROGRAMMED death-ligand 1, *IMMUNE checkpoint inhibitors, *HOSPITAL central service departments, *CONFIDENCE intervals, *OPTIMISM

مصطلحات جغرافية: NETHERLANDS

المؤلفون: Lee, Kyu Sang¹ (AUTHOR), Choi, Euno² (AUTHOR), Cho, Soo Ick³ (AUTHOR), Park, Seonwook³ (AUTHOR), Ryu, Jeongun³ (AUTHOR), Puche, Aaron Valero³ (AUTHOR), Ma, Minuk³ (AUTHOR), Park, Jongchan³ (AUTHOR), Jung, Wonkyung³ (AUTHOR), Ro, Juneyoung³ (AUTHOR), Kim, Sukjun³ (AUTHOR), Park, Gahee³ (AUTHOR), Song, Sanghoon³ (AUTHOR), Ock, Chan‐Young³ (AUTHOR), Choe, Gheeyoung¹ (AUTHOR), Park, Jeong Hwan⁴ (AUTHOR) hopemd@hanmail.net

المصدر: Histopathology. Jul2024, Vol. 85 Issue 1, p81-91. 11p.

مصطلحات موضوعية: *TRANSITIONAL cell carcinoma, *PROGRAMMED death-ligand 1, *IMMUNE checkpoint inhibitors, *ARTIFICIAL intelligence

المؤلفون: Huang, Jiaqi^1,2 (AUTHOR), Yin, Qianqian^2,3,4 (AUTHOR), Wang, Yuqing^2,4 (AUTHOR), Zhou, Xin^4,5 (AUTHOR), Guo, Yunyun^1,2 (AUTHOR), Tang, Yuanjun^2,4 (AUTHOR), Cheng, Rui^1,2 (AUTHOR), Yu, Xiaotong^2,4 (AUTHOR), Zhang, Jie^2,4 (AUTHOR), Huang, Chen^2,4 (AUTHOR), Huang, Zhanya^1,2 (AUTHOR), Zhang, Jianlin^2,4 (AUTHOR), Guo, Zhengyang^2,4 (AUTHOR), Huo, Xiao^2,3,4 (AUTHOR), Sun, Yan^2,4 (AUTHOR), Li, Yanfang^2,4 (AUTHOR), Wang, Hao^1,4 (AUTHOR) wanghaobysy@bjmu.edu.cn, Yang, Jianling^2,4 (AUTHOR) jianlingyang@bjmu.edu.cn, Xue, Lixiang^1,2,3,4,6 (AUTHOR) lixiangxue@hsc.pku.edu.cn

المصدر: Advanced Science. 6/19/2024, Vol. 11 Issue 23, p1-18. 18p.

مصطلحات موضوعية: *PROTEIN stability, *PROGRAMMED death-ligand 1, *COLORECTAL cancer, *IMMUNE checkpoint inhibitors, *DEUBIQUITINATING enzymes